These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10771659)

  • 1. [Leukotriene D4 antagonists].
    Hamanaka N; Nakai H
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):967-72. PubMed ID: 10771659
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes.
    Bäck M; Norel X; Walch L; Gascard J; Mazmanian G; Dahlén S; Brink C
    Eur J Pharmacol; 2000 Aug; 401(3):381-8. PubMed ID: 10936497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene receptors and their selective antagonists.
    Gardiner PJ; Abram TS; Tudhope SR; Cuthbert NJ; Norman P; Brink C
    Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():49-61. PubMed ID: 7771349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leukotriene modifiers].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of leukotrienes in inflammation.
    Henderson WR
    Ann Intern Med; 1994 Nov; 121(9):684-97. PubMed ID: 7944079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry and structure--activity relationships of leukotriene receptor antagonists.
    Bernstein PR
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S220-5; discussion S225-6, S247-8. PubMed ID: 9647603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects of leukotriene-antagonists].
    Chohnabayashi N; Sugiura R; Nishimura N
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():272-6. PubMed ID: 18072343
    [No Abstract]   [Full Text] [Related]  

  • 11. N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4.
    Brown MF; Marfat A; Antognoli G; Chambers RJ; Cheng JB; Damon DB; Liston TE; McGlynn MA; O'Sullivan SP; Owens BS; Pillar JS; Shirley JT; Watson JW
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2451-6. PubMed ID: 9873560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of leukotriene receptor antagonists in asthma therapy.
    Olivieri D; Chetta A
    Monaldi Arch Chest Dis; 1995 May; 50(3):170-2. PubMed ID: 7663484
    [No Abstract]   [Full Text] [Related]  

  • 13. A Tale of Two CysLTs.
    James AJ; Sampson AP
    Clin Exp Allergy; 2001 Nov; 31(11):1660-4. PubMed ID: 11696040
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leukotrienes and shock].
    Oborin AN
    Klin Khir (1962); 1991; (4):60-4. PubMed ID: 1679140
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists.
    Chan CC; Ecclestone P; Nicholson DW; Metters KM; Pon DJ; Rodger IW
    J Pharmacol Exp Ther; 1994 Jun; 269(3):891-6. PubMed ID: 8014876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of sulfido-peptide leukotrienes: application to the design of potent and specific antagonists of leukotriene D4.
    Young RN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():643-6. PubMed ID: 2546403
    [No Abstract]   [Full Text] [Related]  

  • 17. The cysteinyl-leukotriene-1 receptor antagonist zafirlukast is a potent secretagogue in rat and human airways.
    Schmidt R; Staats P; Groneberg DA; Wagner U
    Eur J Pharmacol; 2005 Dec; 527(1-3):150-6. PubMed ID: 16310765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
    Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
    Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
    Liu YC; Khawaja AM; Rogers DF
    Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.